Bangladesh's 2026 measles outbreak — now described as one of the country's worst public health crises in recent history — was not a sudden event but the foreseeable result of systemic vaccine procurement failures and administrative breakdowns, according to a new report by a Canada-based international advocacy group. The Global Centre for Democratic Governance (GCDG), in its report titled Preventable Tragedy: Bangladesh's 2026 Measles Outbreak, concluded that the crisis was entirely avoidable given that measles is a vaccine-preventable disease.

What the Report Found

The GCDG found that the outbreak stemmed from a cascade of failures during 2024–2025, a period spanning the tenure of the former interim government led by Muhammad Yunus. These included disruptions to vaccine supply chains, missed routine immunisations, cancellation of scheduled supplementary immunisation programmes, administrative delays in procurement, and a failure to identify at-risk child populations in time.

Critically, the report noted that Bangladesh had long sourced WHO-approved vaccines through UNICEF's established international supply chain. The interim government replaced this system with an open tender procurement process — a shift that, according to the GCDG, introduced delays that proved fatal to immunisation coverage.

UNICEF Warnings Went Unheeded

According to the report, UNICEF issued repeated formal warnings about an impending vaccine shortage — sending five to six formal letters and holding approximately 10 meetings with the interim government between 2024 and 2026. Despite this, procurement did not keep pace with need.

Bangladesh's routine immunisation programme requires approximately 70 million doses of various vaccines annually. However, only 17.8 million doses were procured using UNICEF's advance funding between August and November 2025. The GCDG noted that UNICEF attributed the shortfall to 'indecision over the procurement method and the lengthy open tender process,' which made timely vaccine acquisition impossible even after funds were allocated.

Vaccination Coverage Collapsed

Citing data from Bangladesh's Expanded Programme on Immunisation (EPI), as reported by Bangladeshi daily Samakal, the GCDG noted that measles vaccination coverage fell to 56.2 per cent in 2025 — the lowest level recorded in the period between 2017 and 2025. WHO subsequently identified a nationwide stock-out of the measles-rubella (MR) vaccine during 2024–2025 and the absence of regular vaccination sessions as the primary contributors to declining immunity among children and the eventual outbreak.

Current Government's Response Criticised

The GCDG also trained its criticism on the current Bangladesh Nationalist Party (BNP) government, which came to power earlier this year, accusing it of failing to respond swiftly to 'known and measurable risks.' Despite warnings about hospital overcrowding, isolation gaps, and referral failures flagged as early as April, the report states that critical measures — including equipment procurement, establishment of temporary isolation units, deployment of health workers, and formulation of standard treatment protocols — were not completed until late May.

The organisation also flagged what it termed 'information opacity' as a distinct and serious failure, criticising the current government's lack of transparency in communicating the scale and status of the outbreak to the public.

What Comes Next

The GCDG report underscores that Bangladesh's measles crisis is a systemic failure rather than an isolated public health event, implicating both the former interim administration and the current government. With vaccination coverage still recovering and public trust in health institutions under strain, experts and international agencies will be watching closely whether Bangladesh can restore routine immunisation rates and rebuild its supply chain safeguards before another preventable outbreak takes hold.